Tag Archives: Nordisk

Novo Nordisk Shares Plummet as Competition Weighs on Sales – The Wall Street Journal

Novo Nordisk Shares Plummet as Competition Weighs on Sales  The Wall Street Journal Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning  The New York Times Novo Nordisk outgoing CEO blames compounded GLP-1s for decline in 2025 outlook  Yahoo Finance Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance  CNBC Novo Stock (NVO) Tumbles. Ozempic, Wegovy Maker …

Read More »

Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again – Reuters

Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again  Reuters Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance  CNBC Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short  Bloomberg.com Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO  Yahoo Finance Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic  MarketWatch Source link

Read More »

Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic – MarketWatch

Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic  MarketWatch Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance  CNBC Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook  Yahoo Finance Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short  Bloomberg Novo Nordisk Stock Plummets After Ozempic, Wegovy Maker Cuts U.S. Outlook  Barron’s Source link

Read More »

Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidance

Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidance

Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its blockbuster Wegovy obesity drug in the key U.S. market. The company also named Maziar Mike …

Read More »